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Background: The finite replicative lifespan of cells, termed cellular senescence, has been proposed as a protective
mechanism against the proliferation of oncogenically damaged cells, that fuel cancer. This concept is further
supported by the induction of premature senescence, a process which is activated when an oncogene is expressed
in normal primary cells as well as following intense genotoxic stresses. Thus, deregulation of genes that control this
process, like the tumor suppressor p53, may contribute to promoting cancer by allowing cells to bypass
senescence. A better understanding of the genes that contribute to the establishment of senescence is therefore
warranted. Necdin interacts with p53 and is also a p53 target gene, although the importance of Necdin in the p53
response is not clearly understood.
Methods: In this study, we first investigated Necdin protein expression during replicative senescence and
premature senescence induced by gamma irradiation and by the overexpression of oncogenic RasV12. Gain and
loss of function experiments were used to evaluate the contribution of Necdin during the senescence process.
Results: Necdin expression declined during replicative aging of IMR90 primary human fibroblasts or following
induction of premature senescence. Decrease in Necdin expression seemed to be a consequence of the
establishment of senescence since the depletion of Necdin in human cells did not induce a senescence-like growth
arrest nor a flat morphology or SA-β-galactosidase activity normally associated with senescence. Similarly,
overexpression of Necdin did not affect the life span of IMR90 cells. However, we demonstrate that in normal
human cells, Necdin expression mimicked the effect of p53 inactivation by increasing radioresistance.
Conclusion: This result suggests that Necdin potentially attenuate p53 signaling in response to genotoxic stress in
human cells and supports similar results describing an inhibitory function of Necdin over p53-dependent growth
arrest in mice.
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The maintenance of genomic integrity relies on the abil-
ity of the p53 tumor suppressor to arrest the cell cycle
thereby allowing correct repair of potentially oncogenic
DNA damage after an insult [1]. This checkpoint is cen-
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distribution, and reproduction in any mediumwhich could result in carcinogenesis. Another level of
protection preventing carcinogenesis is cellular senes-
cence, a process that also involves p53 [2,3]. Replicative
senescence in human cells results from telomere short-
ening as a consequence of each cell division [4]. This
naturally occurring process could be related to the aging
of mammals as the accumulation of senescent cells may
contribute to reduce tissue functionality and may affect
its morphology [3]. On the other hand, stress-induced
senescence also defines a permanent growth arrest
that is triggered by irregular signaling in a cell caused by
an activated oncogene or an unresolved genotoxic stresstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cence result from common mechanisms in which the
tumor suppressors Rb and p53 play a central role [9].
Senescent cells remain metabolically active, with a flat
morphology and are characterized by β-galactosidase ac-
tivity [10]. Some effectors of p53 such as the inhibitor
cyclin-dependent kinase p21, miR34 and PML are well
characterized for their involvement in this permanent
growth arrest [11-13]. However, new targets of p53
are continuously discovered and require extensive
characterization to entirely understand their functions in
the p53 pathways that regulate cell cycle, apoptosis and
senescence. Moreover, p53 regulation is complex and
remains incompletely understood [14].
Necdin has been recently identified as a p53 target
gene [15,16]. We initially observed that Necdin is
increased in polyomavirus large T-antigen expressing
NIH3T3 cells, a mouse model used to unravel early
events in carcinogenesis [16]. In this model, the increase
in Necdin results from a p53-independent mechanism
suggesting that other mechanisms are involved in Nec-
din transcriptional regulation. Necdin was first described
as a growth suppressor with an Rb-like activity by inter-
acting with E2F1 to repress its function [17-19]. How-
ever, we observed that NIH3T3 cells could grow
efficiently even with high Necdin expression [16]. The
role of Necdin in cancer remains poorly defined. A de-
crease in expression is observed in melanomas [20],
while pancreatic cancer presents increased expression
through the loss of imprinting in the Necdin gene [21].
We hypothesized that Necdin expression could be asso-
ciated with better outcomes, as suggested since Necdin
is associated with a better prognosis in breast cancer
[22] and by our previous results revealing that Necdin
expression is limited to borderline ovarian cancer, which
is usually p53 wild type cancer [16].
Necdin is linked to p53 pathways suggesting that it
may impact cancer development. The initial evidence by
Taniura and al. [19], demonstrated a possible interaction
between Necdin and p53. It was also reported that Nec-
din has the ability to suppress p53-induced apoptosis
[19,23]. We previously observed that Necdin expression
allowed cells to overcome the growth arrest induced by
p53 activation [16]. In addition, Necdin can affect post-
translational modification of p53 by interacting with
Sirt1 [23]. Sirt1 is a deacetylase [24] and the interaction
of Sirt1 with Necdin potentiates its capacity to decrease
p53 acetylation leading to the reduction of p53 activity
[23]. Therefore, Necdin seems to be closely related to
p53 since it is a p53 target gene and it can negatively
modulate p53-dependent growth arrest and apoptosis.
Its relationship to p53 activity needs to be further clari-
fied. These observations prompted us to explore the
possible impact of Necdin during senescence, anotherimportant role of p53 in preventing cancer. Here we
demonstrate that while Necdin expression levels decline
in both replicative and premature senescence, modula-
tion of its expression does not affect human primary cell
life span. However, high levels of Necdin contribute to
an increased radioresistance in primary cells. Taken to-
gether, these observations are consistent with an inhibi-
tory effect of Necdin on the p53 pathway and suggest a




Low passage IMR90 normal human fibroblasts [25] were
a generous gift from Dr. Christian Beausejour (Centre de
recherche du CHU Ste-Justine, Montreal). Primary cells
were kept at 37°C under 5% CO2 and a low O2 condition
(5%), and were maintained in Dulbecco’s modified eagle
medium (DMEM) supplemented with 10% FBS. The
number of living cells was determined using the CASYW
cell counter model TT. Proliferation of IMR90 cells
was assessed by population doubling according to the
following formula: last PD+ (Log (final cell number) -
Log (initial cell plated) x 3.32).
Vectors and infection
All constructs for lentivirus production were derived
from a previously described expression system [26]. The
human NDN gene was excised from pOBT7 containing
full length human NDN (Open Biosystems, MHS1011-
61084) and inserted in the 686–1 vector (pENTR4 no
ccdB, Addgene number 17424). Recombination of this
construct was performed with the destination expression
vectors 685–3 or 670–1 (pLenti CMV/TO Neo DEST
and pLenti CMV/TO Puro DEST: Addgene number
17292 and 17293) using the Gateway LR ClonaseW en-
zyme mix (Invitrogen). Control vector was generated by
recombination of the empty pENTR4 no ccdB with the
same destination vectors. GSE22 (encoding an interfer-
ing p53 fragment) have been previously described [27].
H-RasV12 in 685–3 vector was a gift from Christopher
Wiley (from J. Campisi’s lab). pLKO.1 lentiviral shRNA
vectors targeting human NDN gene (shNdn1
(TRCN0000020085), shNdn2 (TRCN0000020086)) or
GFP as a control (shGFP (RHS4459)) were purchased
from Open biosystems.
Lentiviruses were produced by co-transfection of the
different pLenti contructs together with ViraPower Len-
tiviral Packaging Mix (Invitrogen) in the 293FT pack-
aging cell line. 72 hrs later, supernatants were collected
and viruses were concentrated by ultracentrifugation.
Infections were performed on 5–7.5 x 105 cells overnight
in the presence of polybrene. Appropriate selection was
applied 48 hrs later.
Figure 1 Expression of Necdin is related to p53 activity in
primary human fibroblasts. (A) Stimulation of IMR90 cells for
24 hrs with Nutlin-3 (2.5 μM) to induce p53 resulted in increase in
Necdin protein level (B) Necdin, p21 and p53 protein expression in
IMR90 cells expressing GSE22 inhibitor peptide.
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(TetR) were generated by infection with lentiviruses con-
taining the 716–1 vector (pLenti-CMVtetR Blast,
Addgene #17492).
Senescence
Senescent IMR90 cells were generated by irradiating
cells at 20 Gy in a Gammacell irradiator. Cell extracts
were harvested at indicated times for western blot ana-
lysis. For oncogene-induced senescence, IMR90 cells
were infected with oncogenic RasV12 containing lenti-
virus. Senescence was assessed by senescence-associated
ß-galactosidase (SA-ß-gal) staining [10] using a Senes-
cence Detection Kit (BioVision) in 6-well or 12-well cul-
ture plates according to the manufacturer’s instructions.
Cells were plated 24 hrs before staining.
Growth arrest and FACS
For serum starvation, cells were washed 24 hrs after
plating and medium was replaced by DMEM containing
0.1% FBS. After 24 hrs of exposure to low or normal
serum conditions, cells were collected, fixed with etha-
nol and stained with propidium iodide. DNA content
analysis was performed using a Coulter EPICS XL-MLC
Flow Cytometer.
Western blotting
Cells were lysed with a buffer containing 50 mM Tris
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% TRITON™
X-100 and protease inhibitors (Complete Protease Inhibi-
tor Cocktail Tablets, Roche). Western blot analyses were
done on nitrocellulose membranes hybridized with vari-
ous antibodies: from Santa Cruz p53 (DO-1, sc-126), p21
(F5, sc-6246), H-Ras (F-235, sc-29), p16 (JC-8, sc-
56330), PCNA (FL-261, sc-7907), from Millipore (Up-
state) Necdin (07–565) and from Abcam β-actin (AC-
15, ab6276). Secondary HRP-conjugated antibodies
were all purchased from Santa Cruz.
p53 stimulation
One day after 1 x 105 cells were seeded in 6-well plates
they were treated for 24 hrs with 2.5 μM Nutlin-3
(Sigma) or DMSO for the untreated control. Cells were
collected and total protein extracts were performed in
the lysis buffer as described above. p53 accumulation
was assessed by Western blot.
Colony formation assay
For stress-induced senescence analysis, we first trans-
duced IMR90 cells containing the tetracycline repressor
(IMRtetR) with the vector of interest (empty vector and
hNdn) and IMR90 cells with GSE22 or shRNA (shNdn1,
shNdn2 and shGFP). After an appropriate period ofselection, cells were exposed to irradiation. For each
population, 100 untreated cells were seeded to deter-
mine plating efficiency. 1.6x103 cells irradiated with a
dose of 2 Gy were plated in 100 mm. All conditions
were performed in triplicate. Medium was replaced every
third day and cells were stained after 12 days with a
crystal violet solution. Percentage of colonies was deter-
mined by the following formula: number of colonies in
irradiated cells/(number of colony in untreated cells x
dilution factor). Since Necdin expression was inducible,
we chose to maintain all populations in this experiment
in medium containing doxycycline to avoid variation.Results
Necdin and p53 expression are linked in human
fibroblasts
Physical and functional interactions between Necdin
and p53 have been reported in both mouse and human
cancer cell lines [15,16,19]. It was of interest to deter-
mine if this link can also be found in normal human
primary cell line. In order to induce p53, human pri-
mary IMR90 fibroblasts were treated with Nutlin-3, a
mdm2 antagonist that causes an accumulation of p53
in cells [28]. Nutlin-3 treatment induced an accumula-
tion of p53 at the protein level (Figure 1A). Concomi-
tant with p53 induction, the increase in Necdin
occurred in conjunction with increased p21, a known
p53-target gene (Figure 1A). Inversely, when a domin-
ant negative peptide suppressor of p53 activity, GSE22
[29,30], was transduced in IMR90 using a lentivirus
construct, we observed a decrease in both Necdin and
p21 protein levels (Figure 1B). The presence of GSE22
in cells is well known to induce the accumulation of a
non-functional p53 as a result of interaction of the pep-
tide with p53 (Figure 1B). These results are consistent
with earlier results in cancer cell lines, and demonstrate
a link between Necdin and p53 epression in human pri-
mary cells.
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To investigate the connection between Necdin and cel-
lular senescence, we first characterized Necdin expres-
sion during the normal process of replicative aging of
cells in vitro. Human primary fibroblasts (IMR90) were
maintained in culture for various periods of time thereby
generating populations at three different population
doubling (PD). Young (PD30), late passage (PD56) and
senescent (PD69) fibroblasts were characterized for
senescence-associated β-galatosidase activity (SA-β-Gal)
(Figure 2A and B), a biomarker of senescence [10].
Young and presenescent fibroblasts showed low staining
(6% and 20% respectively) while the older cell culture
had up to 70% SA-β-Gal of positive cells (Figure 2B).
When these cells were compared at the protein level, a
decrease in Necdin expression that correlated with cellu-
lar aging was clearly observed. Necdin was present in
young cells, moderately in later passages and barely de-
tectable in senescent cells (Figure 2C). This variation
was accompanied by a characteristic upregulation of the
cell cycle inhibitor p16INK4A, which was noticeable in
late passage cells and sustained in senescent cells. There
was no difference in p53 levels between the various
populations (Figure 2C). These results revealed that
Necdin expression declines when cells reach replicative
senescence.Figure 2 Necdin levels decrease during replicative aging in
primary cells. (A) Representative micrographs of senescence-
associated β-galactosidase staining of IMR90 cells at early passage
(PD30), late passage (PD56) and senescence (PD69). (B) Quantification
of senescent cells represented by the average of SA-β-gal positive cells.
Error bars represent standard deviation of counts performed on six
different fields. (C) Western blot analysis of protein content from IMR90
cells at corresponding population doubling. All extracts were collected
the same day from the three different populations.Premature senescence is accompanied by a decrease in
necdin level
To further characterize Necdin expression during senes-
cence, we also followed its expression in situations
where senescence was induced in response to a cellular
insult. Premature senescence is triggered when an onco-
gene is overexpressed or present in an activated form in
a cell, and is thought to represent a fail-safe mechanism
to prevent carcinogenesis [5,31]. This senescence is
known as oncogene-induced senescence (OIS). We used
a human activated mutant form of Ras (Ha-RASv12)
[32], which induces OIS soon after its expression in nor-
mal human fibroblasts when expressed alone [5]. After
transduction of oncogenic RasV12, cells usually grew for
a short period of time before entering into a permanent
growth arrest [33,34]. Different time points were
selected after infection to evaluate protein content dur-
ing the proliferation stage (day 4) and in senescent cells
(day 7). The transduction of RasV12 resulted in high
levels of Ras at day 7 compared to control cells where
endogenous Ras was not detected (Figure 3A). However,
four days after infection, the level of Ras was more mod-
erate (Figure 3A). Transduction of RasV12 did not in-
duce a variation of Necdin during the proliferation stage
(day 4), but the Necdin level diminished when cells
reached senescence one week after infection (Figure 3A).
As expected, p16INK4A levels gradually increased from
day 4 in RasV12 expressing cells compared to control.
PCNA was included as a readout of the proliferative
capacity of the different populations and showed a
marked decrease consistent with growth arrest at day 7
in the RasV12-transduced population.
Another method to induce premature senescence in
human normal cells is exposure to stresses causing persist-
ent DNA damages [7]. In order to induce stress-induced
premature senescence (SIPS), cells were exposed to
gamma irradiation. Cells that were irradiated at 20 Gy
progressively entered a senescence state, which was
marked by an increase in p16INK4A expression over time
(Figure 3B). This increase in p16INK4A was accompanied
by a decrease in Necdin protein levels (Figure 3B). Finally,
we evaluated whether the decrease in Necdin levels
observed with senescence was also seen in transient
growth arrest. Cells were subjected to serum starvation for
either 24 or 48 hours, which induced a cell cycle arrest in
G1 as confirmed by DNA content (Figure 3C). Western
blot analysis revealed a constant level of Necdin protein
during this transient growth arrest (Figure 3D).
Thus, during both oncogene-induced (RasV12) and
stress-induced (irradiation) senescence, Necdin levels
decreased with the establishment of senescence. The de-
crease in Necdin expression is specific to permanent
growth arrest since serum depletion did not generate the
same effect.
Figure 3 Premature senescence is characterized by Necdin downregulation. (A) Oncogene-induced senescence induced by RasV12
transduction of IMR90 cells caused a decrease in Necdin levels. Protein extracts were collected at the proliferation stage (day 4) and senescence
(7 days after infection) (B) Stress-induced senescence generated by irradiation of IMR90 cells with 20 Gy also resulted in decreased Necdin level.
Western blot analysis revealed protein modulation over time. (C-D) Necdin variation is not observed with transient arrest induced by serum
starvation. (C) Flow cytometry analysis of IMR90 cells showed growth arrest after 24 hrs of serum starvation (0.1% FBS) compared to normal
culture conditions (10% FBS). (D) Necdin protein levels of cells in normal or low serum conditions did not change.
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These results raised the possibility that Necdin may have
an inhibitory effect on senescence or that the decrease
in Necdin may be a consequence of senescence. Thus, it
was of interest to determine if sustained Necdin expres-
sion could allow cells to extend their proliferative life-
span. Lentiviruses were used to deliver human Necdin
cDNA in IMR90 cells. Because we previously observed a
short-term growth inhibition with Necdin expression in
the mouse NIH3T3 immortal cell line [16], we used an
inducible system to express Necdin in IMR90 expressing
the tetracycline repressor (IMRtetR). This inducible sys-
tem allowed us to assess the impact of Necdin expres-
sion upon induction after an extended period of
selection due to the low titer of viruses produced from
Necdin cDNA. Population doublings were followed until
cells naturally reached replicative senescence. Uponinduction by doxycycline, a more stable analogue of
tetracycline, we did not observe any effect of Necdin
overexpression on the growth rate of IMR90 cells
(Figure 4A). Moreover, IMR90 cells expressing Necdin
did not present an extended life span compared to vec-
tor expressing control as both populations arrested after
the same number of population doubling (Figure 4A).
Neither proliferation nor life span was affected by the
presence of doxycycline (Figure 4A and B). Induction of
Necdin expression by doxycycline was monitored at dif-
ferent time points. As presented in Figure 4C, ectopic
expression of Necdin was maintained even when cells
are arrested although with a lower efficiency than seen
in early passages.
Inversely, we also analyzed the effect of decreasing Nec-
din expression in IMR90 cells. Protein level analysis con-
firmed a significant reduction in Necdin by using two
Figure 4 The effect of Necdin overexpression on cellular life span. Population doubling of an IMR90tetR population expressing inducible
Necdin or empty vector (A) with or (B) without doxycycline induction (arrow in A indicates the time where induction began). Population
doubling monitoring begins after the selection period where cells achieve PD40 (corresponding to PD0 on the graph). (C) Protein extracts at two
different time points showed efficient Necdin induction with doxocyclin. Representative results of three independent experiments.
Figure 5 The effect of Necdin depletion on premature
senescence. (A) Protein expression level in IMR90 cells showed
efficient depletion in Necdin expression by shRNA and
overexpression of RasV12, which served as a positive control of
senescence induction. (B) Senescence-associated β-galactosidase
staining 14 days after lentiviral infection demonstrated senescence
only in RasV12-expressing cells. (C) Quantification of senescent cells
represented by the average of SA-β-gal positive cells. Mean of six
different fields ± standard deviation.
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vector containing shRNA against GFP served as negative
control and the oncogene RasV12 served as positive con-
trol for premature senescence (Figure 5A). Elevation of
p16 was visible in RasV12 expressing cells at 7 days after
infection as well as a modest increase in one of the two
populations where shNdn were expressed (Figure 5A).
However, expression of RasV12 did induce premature sen-
escence phenotype as showed by flat morphology and
determined by SA-β-galactosidase staining but neither of
the shRNA population presented these characteristics
(Figure 5B). Quantification of SA-β-gal staining revealed
that, as expected, a significant portion of cells was posi-
tive with RasV12 expression (more than 50%) compared
to control shGFP (13%) and cells expressing shNDN
showed a similar or decrease in SA-β-galactosidase
staining (3% and 8%) compared to negative control
shGFP (Figure 5C). Take together, these results sug-
gested that, under normal conditions, positive or nega-
tive variations in Necdin expression did not affect the
cellular proliferation or the life span of normal human
IMR90 cells.
Necdin overexpression provides radio-resistance in
human normal cells
Although Necdin did not appear to affect senescence in
normal conditions despite its involvement in Rb-E2F1
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din expression could modify the cellular response to
stress-induced senescence. To characterize the effect of
Necdin modulation under stress conditions, cells where
Necdin was overexpressed or targeted by shRNA were
irradiated with a dose of 2 Gy to induce DNA damage.
Under these conditions, DNA double-strand breaks
(DSBs) are induced in all nuclei [35] and p53 is induced
(Additional file 1). A single-cell colony formation assay
after irradiation revealed the proliferative survival poten-
tial of each population. As a control, the inhibitor of p53
(GSE22) was expressed as p53 inactivation in normal
cells can result in radioresistance [8]. Colony quantifica-
tion showed an increase in proliferation efficiency when
p53 was inactivated with proliferative survival of 25%
compared to only 12% in control cells (Figure 6A). Simi-
larly, expression of Necdin resulted in 20% of proliferat-
ing colonies suggesting a similar effect to p53
inactivation (Figure 6A). No significant variation was
observed when Necdin expression was depleted by
shRNA (shGFP 6%, shNdn 6% and 8%). These data sug-
gest that Necdin overexpression in human cells increases
their resistance to irradiation thus supporting the pos-
sible inhibitory activity of Necdin over a p53 function.
Discussion
Low necdin expression as a marker of senescence
Replicative senescence marks the end of the proliferative
state in cells when telomeres reach a critical length [4].
This mechanism is relevant in limiting aberrant prolif-
eration and may contribute to cancer prevention [36].
By comparing IMR90 cells at high or low population
doublings, we demonstrate a reduction of the Necdin
protein levels over time, while p16 increases, which is
the mark of an irreversible arrest [29,37,38]. Lee and al.
[39] identified Necdin among the gene expression pro-
files in skeletal muscle of aging mice, where Necdin
levels decrease with age. In contrast, Necdin was upre-
gulated upon caloric restriction, a process that retardsFigure 6 Necdin overexpression confers radioresistance. Colony
formation assays were performed on human fibroblasts exposed to
2 Gy of ionizing irradiation. Percentage of recovery was evaluated
12 days after irradiation in (A) IMR90tetR cells overexpressing human
Necdin, empty vector and GSE22 or (B) IMR90 cells where Necdin
expression was targeted by two different shRNAs compared to
control shGFP. Mean± standard deviation. (*P= 0.02, t-test).aging in mice [39]. Our result confirmed that the
decreased Necdin levels seen in aged mouse skeletal
muscle can be reproduced with normal human fibro-
blasts in culture. The decrease in Necdin expression was
also consistently observed in telomere-independent pre-
mature senescence induced by irradiation. It was also
observed, but to a much lower extent, in premature sen-
escence resulting from the expression of the activated
oncogenic Ras (RasV12). Although the observed reduc-
tion in Necdin protein was subtle, another group has in-
dependently reported that Necdin mRNA was part of
the list of downregulated genes following Ras-induced
senescence [34], supporting our general finding that
Necdin is downregulated during cellular senescence.
In contrast to senescence, cellular quiescence is a re-
versible cell cycle arrest since cells may re-enter the cell
cycle when the restriction is removed [29,37]. Interest-
ingly, in a transient G1 arrest, Necdin remained
expressed, suggesting that the decrease in Necdin is lim-
ited to permanent growth arrest and may be a marker of
senescent cells. Necdin levels in other primary cells need
to be analyzed since the molecular signature at senes-
cence largely depends on the cell type [40].
Like Necdin, many genes involved in cell cycle pro-
gression show altered expression in senescent cells as
both proliferation-promoting proteins and their negative
regulators decrease when human fibroblasts reach senes-
cence, as exemplified by Rb and E2F1 [34,41]. Necdin
interacts with E2F1, E2F4 and also affects expression of
the Rb family of genes [42]. One interpretation of these
findings is that Necdin may affect cellular senescence.
To test this hypothesis, ectopic expression of Necdin
was used. We found that overexpression of Necdin did
not extend the replicative life span of primary human
fibroblasts. Moreover, the sustained expression of Nec-
din over time in this experiment suggested that the
complete elimination of Necdin expression is not essen-
tial for senescence to occur.
There are various examples in the literature where
proteins, possessing properties similar to Necdin, can in-
duce premature senescence when depleted in IMR90
cells. The knock down of BS69 and p400, also known to
interact with viral proteins, induced a premature senes-
cence characterized by p21 and p53 upregulation
[43,44]. BS69 and p400, like Necdin, can form a complex
with p53 at the p21 promoter to repress transcription
[19,44], although it is not known if Necdin is part of the
same complex. Moreover Sirt1, a partner of Necdin [23],
can increase the risk of cancer due to its capacity to
downregulate p53 activity by deacetylating this tumor
suppressor [24,45,46]. Accordingly, Sirt1 inhibition also
induces a senescence-like phenotype in IMR90 cells [47].
From these data, we expected that knock down of en-
dogenous Necdin by shRNA might also induce
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p21 de-repression. However, shNDN-directed loss of
Necdin expression did not induce premature senescence
in IMR90 cells. Perhaps, under non-stress conditions, a
complementary protein may contribute to maintaining
Necdin function in its absence. For example, other
members of the MAGE family like NDNL2, also known
as MAGE-G1, [48], are expressed in a wide variety of
tissues including fibroblasts [49] and shares many func-
tions with Necdin. Alternatively, loss of Necdin might
not be sufficient to activate p53 in the absence of others
p53 stabilization signals.
Necdin is a maternally imprinted gene and its pro-
moter contains many CpG sites for methylation regula-
tion [50]. Consistent with this, the inhibition of DNA
methyltransferase (DNMT) by 5-aza-2′-deoxycytidine
(5AZA-dC) has been shown to induce Necdin expres-
sion in some cancerous cell lines [51]. During senes-
cence establishment, epigenetic changes occur inducing
important chromatin structure modifications; some at
specific sites while other reflect a more global change.
Global DNA methylation status decreases with aging by
comparison to young counterparts and immortalized
cells [52,53]. A specialized redistribution in chromatin
heterochromatin, called senescence-associated hetero-
chromatic foci (SAHF), is also associated with cellular
senescence [33]. The mechanism is only partially under-
stood; the genomic loci affected by this structure often
contain proliferation-promoting genes such as E2F1 tar-
get genes [33]. Moreover, SAHF are not observed in qui-
escent cells. It is possible that the decrease in Necdin
levels during aging could be the result of hypermethyla-
tion or others senescence associated modifications at
specific sites.
Necdin expression confers resistance to ionizing
irradiation
Necdin expression can exert an effect on normal cells as
an increase in Necdin level confers resistance to ionizing
radiation. At the employed dose, DNA double-strand
breaks were induced in all cells and the physiological
consequence is the induction of a DNA damage re-
sponse activating p53. Thus, these damages caused cell
cycle arrest and need to be repaired before cells can re-
sume proliferation. When damages cannot be properly
repaired, apoptosis or senescence are two possible cellu-
lar outcomes. Consequently, we observed that cells un-
able to form colonies showed enlarged and flat
morphology of senescent cells in all populations tested
(data not shown). This is expected for normal fibroblasts
that are relatively resistant to apoptosis upon irradiation
[54]. Apoptosis was probably also induced to a low level
but could not be monitored due to the low cell densities
used in these experiments.An appropriate response to genotoxic stress is based
on the capacity to sense the damage, to activate the cell
cycle checkpoint and to repair the damage [55]. Two
principal conditions may explain an increase in resist-
ance to irradiation in a normal cell. First, an enhanced
ability to repair the DNA damage could promote sur-
vival. Second, a failure in activating cell cycle check-
points will contribute to the maintenance of cells in a
proliferative state despite the presence of a genotoxic
stress. This could result from inefficient sensing up-
stream of the p53 pathways or by a reduction in p53
downstream signaling. This is what was reproduced with
the positive control expressing a peptide inhibitor of p53
(GSE22) resulting in a marked increase in colony forma-
tion consistent with the notion that a decrease in p53
function increases resistance to irradiation. We observed
and others have shown previously that Necdin can inter-
fere with p53-responses [16,19,23]. These data suggest
that increased radioresistance associated with Necdin
may be related to its ability to directly influence the
p53-response. Necdin may also confer radioresistance by
inhibiting radiation-induced apoptosis since Necdin can
negatively modulate caspase activation upon genotoxic
stress [56,57], but this is unlikely in fibroblast in re-
sponse to irradiation [54]. Further evidence supporting
Necdin’s ability to contribute to radioresistance is a
microarray analysis of the gene expression profiles pro-
duced by radiosensitive and radioresistant esophageal
carcinoma cell lines. In this study, Necdin expression
was higher in radioresistant cells [58] which is consistent
with the observation of the present study.
Conclusion
The results of the present study suggest that Necdin
function in regulating p53 responses is revealed only
under stress conditions. In the absence of exogenous
genotoxic stress, Necdin has no effect on normal cellular
life span in human cells.
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